Trial Profile
Study to evaluate the safety and efficacy of canakinumab in patients with familial mediterranean fever : A retrospective chart review.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Canakinumab (Primary)
- Indications Familial Mediterranean fever
- Focus Adverse reactions; Therapeutic Use
- 26 Aug 2015 New trial record